Neovasc Inc. Neovasc Inc. is a specialty medical device company that develops, manufactures and markets products for the rapidly growing cardiovascular marketplace.  Its products include the Neovasc Reducer™ for the treatment of refractory angina, the Tiara™ valve in development for the transcatheter treatment of mitral valve disease, and a line of advanced biological tissue products that are used as key components in a variety of third-party medical products, such as transcatheter heart valves.

Industries:
Medical | Pharmaceuticals

Latest

May 23, 2019, 09:17 ET New Tiara and Reducer Data Presented in Several Presentations at the EuroPCR 2019 Conference in Paris

NASDAQ, TSX: NVCN VANCOUVER, May 23, 2019 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve...


May 22, 2019, 17:30 ET Neovasc Announces Positive Two-Year Follow-up Safety and Efficacy Data for the Neovasc Reducer™ in a Peer Reviewed Article in the International

NASDAQ, TSX: NVCN VANCOUVER, May 22, 2019 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve...


May 16, 2019, 20:00 ET Neovasc Announces Closing of Private Placement of Convertible Debt and Common Shares for Gross Proceeds of US$11.5 Million

NASDAQ, TSX: NVCN VANCOUVER, May 16, 2019 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ:NVCN)(TSX:NVCN) announced today that it has closed its previously announced private placement (the...


May 14, 2019, 07:00 ET Neovasc Announces Private Placement of Convertible Debt and Equity for Gross Proceeds of US$11.5 Million

Upon closing of this agreement, cash and cash equivalents is expected to support operations into Q1 2020 NASDAQ, TSX: NVCN VANCOUVER, May 14, 2019 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company")...


May 09, 2019, 16:00 ET Neovasc Announces First Quarter 2019 Financial Results

NASDAQ, TSX: NVCN Recent Highlights Announced the 1,000th recipient of a Neovasc ReducerTM ("Reducer") implant Company sponsored Reducer Symposium attended by over 100 attendees at the 85th Annual...


May 06, 2019, 08:55 ET Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer™

NASDAQ, TSX: NVCN VANCOUVER, May 6, 2019 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve...


May 03, 2019, 07:30 ET Neovasc to Announce First Quarter 2019 Financial Results on Thursday, May 9th

Conference Call Scheduled for 4:30 pm Eastern Time on May 9th NASDAQ, TSX: NVCN VANCOUVER, May 3, 2019 /CNW/ - Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVCN), a leader in the...


Apr 26, 2019, 07:30 ET Neovasc Provides Highlights from Annual Conference of the DGK, the German Society of Cardiology; Symposium Generates Growing Support for Reducer

NASDAQ, TSX: NVCN VANCOUVER, April 26, 2019 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve...


Apr 17, 2019, 15:42 ET Neovasc Announces Resolution of Last Remaining Active Litigation

NASDAQ, TSX: NVCN VANCOUVER, April 17, 2019 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve...


Apr 17, 2019, 07:50 ET Neovasc Announces Peer Reviewed Publication in the International Journal of Cardiology Demonstrating that the Neovasc Reducer™ Improves Diastolic

NASDAQ, TSX: NVCN VANCOUVER, April 17, 2019 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve...


Mar 21, 2019, 16:01 ET Neovasc Announces Fourth Quarter and Fiscal Year 2018 Financial Results

NASDAQ, TSX: NVCN Recent Highlights The U.S. Food and Drug Administration (the "FDA") granted Breakthrough Device designation to the Neovasc Reducer™ (the "Reducer") for the treatment of refractory...


Mar 21, 2019, 07:50 ET Neovasc Wins German Court Appeal; Announces German Court's Decision to Dismiss CardiAQ's Claim to Co-inventorship of a European Patent for Tiara™

NASDAQ, TSX: NVCN VANCOUVER, March 21, 2019 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve...


Mar 19, 2019, 07:50 ET Reducer Featured in Presentation at American College of Cardiology's Annual Meeting

NASDAQ, TSX: NVCN VANCOUVER, March 19, 2019 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve...


Mar 15, 2019, 14:30 ET Neovasc Announces Closing of $5 Million Public Offering of Common Shares

NASDAQ, TSX: NVCN VANCOUVER, March 15, 2019 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN / TSX: NVCN) announced today that it has closed its previously announced underwritten...


Mar 14, 2019, 16:01 ET Neovasc Completes Successful Quality System Surveillance Audit

NASDAQ, TSX: NVCN VANCOUVER, March 14, 2019 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve...


Mar 13, 2019, 16:30 ET Neovasc to Announce Year Ended December 31, 2018 Financial Results on Thursday, March 21

Conference Call Scheduled for 4:30pm Eastern Time NASDAQ, TSX: NVCN VANCOUVER, March 13, 2019 /CNW/ - Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of...


Mar 13, 2019, 06:20 ET Neovasc Announces Pricing of $5 Million Public Offering of Common Shares

NASDAQ, TSX: NVCN VANCOUVER, March 13, 2019 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN / TSX: NVCN) announced today the pricing of its previously announced underwritten public...


Mar 12, 2019, 16:01 ET Neovasc Announces Proposed Public Offering of Common Shares

NASDAQ, TSX: NVCN VANCOUVER, March 12, 2019 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN / TSX: NVCN) announced today that it has commenced a proposed underwritten public offering...


Mar 12, 2019, 09:15 ET Neovasc Announces Agreements to Exchange Outstanding Warrants for Shares

NASDAQ, TSX: NVCN VANCOUVER, March 12, 2019 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN) (TSX: NVCN) announced today that it has entered into exchange agreements ("Exchange...


Mar 05, 2019, 15:45 ET Neovasc Announces Reducer™ Implant "Live Case" at the CRT Meeting in Washington, DC

NASDAQ, TSX: NVCN VANCOUVER, March 5, 2019 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve...


Mar 04, 2019, 13:00 ET Neovasc's Tiara™ Mitral Valve Replacement Technology Featured in Update Presentation at the CRT 2019 Meeting

NASDAQ, TSX: NVCN VANCOUVER, March 4, 2019 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve...


Feb 28, 2019, 14:55 ET Neovasc announces closing of $5 million public offering of common shares

NASDAQ, TSX: NVCN VANCOUVER, Feb. 28, 2019 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN / TSX: NVCN) announced today that it has closed its previously announced underwritten public ...


Feb 27, 2019, 16:30 ET Neovasc to Present Corporate Overview at the 8th Annual SVB Leerink Global Healthcare Conference

NASDAQ, TSX: NVCN VANCOUVER, Feb. 27, 2019 /CNW/ - Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ:NVCN) (TSX:NVCN), a leader in the development of minimally invasive transcatheter mitral valve...


Feb 26, 2019, 06:00 ET Neovasc Announces Pricing of $5 Million Public Offering of Common Shares

NASDAQ, TSX: NVCN VANCOUVER, Feb. 26, 2019 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN / TSX: NVCN) announced today the pricing of its previously announced underwritten public...


Feb 25, 2019, 16:01 ET Neovasc Announces Proposed Public Offering of Common Shares

NASDAQ, TSX: NVCN VANCOUVER, Feb. 25, 2019 /CNW/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN / TSX: NVCN) announced today that it has commenced a proposed underwritten public offering...